Beckley Psytech Raises £14m ($18.6m) to Advance Development of 5-MeO-DMT for Neuropsychiatric Diseases Post published:December 19, 2020 Post category:News
Beckley Psytech appoints leading experts to Scientific Advisory Board Post published:November 5, 2020 Post category:Press Release
Beckley Psytech Reveals Scientific Advisory Board Consisting of Renowned Psychedelic Experts Post published:August 18, 2020 Post category:Press Release